Annemarie B van der Aart-van der Beek

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Venues

Diabetes, obesity & metabolism

Nature reviews. Nephrology

Clinical pharmacokinetics

Martini Ziekenhuis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Martini Ziekenhuis

Netherlands

PharmD :: Klinische farmacie

Publications

Annemarie B van der Aart-van der Beek, Rudolf A de Boer, Hiddo J Lambers Heerspink
Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nature reviews. Nephrology 18 (5) (2022)
Annemarie B van der Aart-van der Beek, David Z I Cherney, Gozewijn D Laverman, Bergur Stefansson, Daniel H van Raalte, Klaas Hoogenberg, Daniel Reyner, Qiang Li, Gian Luca Di Tanna, Peter J Greasley, Hiddo J Lambers Heerspink
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials. Diabetes, obesity & metabolism 23 (8) (2021)
Annemarie B van der Aart-van der Beek, Jeroen V Koomen, Claire C J Dekkers, Sean J Barbour, David W Boulton, Ron T Gansevoort, Peter J Greasley, Abdul Halim Abdul Gafor, Gozewijn D Laverman, Qiang Li, Soo Kun Lim, Jasper Stevens, Marc G Vervloet, Sunita Singh, Daniel C Cattran, Heather N Reich, David Z I Cherney, Hiddo J L Heerspink
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease. Clinical pharmacokinetics 60 (4) (2021)
Charlotte C van Ruiten, Annemarie B van der Aart-van der Beek, Richard G IJzerman, Max Nieuwdorp, Klaas Hoogenberg, Daniel H van Raalte, Hiddo J Lambers Heerspink
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial. Diabetes, obesity & metabolism 23 (8) (2021)
Annemarie B van der Aart-van der Beek, Lindsay E Clegg, Robert C Penland, David W Boulton, C David Sjöström, Robert J Mentz, Rury R Holman, Hiddo J Lambers Heerspink
Effect of once-weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial. Diabetes, obesity & metabolism 22 (12) (2020)
Annemarie B van der Aart-van der Beek, Daniel H van Raalte, Cristian Guja, Klaas Hoogenberg, Lisa J Suchower, Elise Hardy, C David Sjöström, Hiddo J Lambers Heerspink
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials. Diabetes, obesity & metabolism 22 (9) (2020)
Annemarie B van der Aart-van der Beek, Hiddo J L Heerspink
Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice. Nature reviews. Nephrology 16 (8) (2020)

Annemarie B van der Aart-van der Beek.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Annemarie B van der Aart-van der Beek